Accelerate Diagnostics EPS - Earnings per Share 2010-2024 | AXDXQ
Accelerate Diagnostics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Accelerate Diagnostics Annual EPS |
| 2024 |
$-2.15 |
| 2023 |
$-4.94 |
| 2022 |
$-7.61 |
| 2021 |
$-12.59 |
| 2020 |
$-14.00 |
| 2019 |
$-15.50 |
| 2018 |
$-16.20 |
| 2017 |
$-11.80 |
| 2016 |
$-12.90 |
| 2015 |
$-10.10 |
| 2014 |
$-7.10 |
| 2013 |
$-4.10 |
| 2012 |
$0.00 |
| 2012 |
$-4.30 |
| 2011 |
$-0.40 |
| 2010 |
$0.60 |
| 2009 |
$-0.70 |
| Accelerate Diagnostics Quarterly EPS |
| 2024-12-31 |
$-0.32 |
| 2024-09-30 |
$-0.59 |
| 2024-06-30 |
$-0.50 |
| 2024-03-31 |
$-0.74 |
| 2023-12-31 |
$-0.32 |
| 2023-09-30 |
$0.06 |
| 2023-06-30 |
$-2.97 |
| 2023-03-31 |
$-1.71 |
| 2022-12-31 |
$-1.35 |
| 2022-09-30 |
$-1.83 |
| 2022-06-30 |
$-2.43 |
| 2022-03-31 |
$-2.00 |
| 2021-12-31 |
$-3.39 |
| 2021-09-30 |
$-1.50 |
| 2021-06-30 |
$-3.60 |
| 2021-03-31 |
$-4.10 |
| 2020-12-31 |
$-3.30 |
| 2020-09-30 |
$-3.30 |
| 2020-06-30 |
$-3.50 |
| 2020-03-31 |
$-3.90 |
| 2019-12-31 |
$-4.00 |
| 2019-09-30 |
$-3.70 |
| 2019-06-30 |
$-3.80 |
| 2019-03-31 |
$-4.00 |
| 2018-12-31 |
$-4.10 |
| 2018-09-30 |
$-4.10 |
| 2018-06-30 |
$-4.30 |
| 2018-03-31 |
$-3.70 |
| 2017-12-31 |
$-2.90 |
| 2017-09-30 |
$-3.10 |
| 2017-06-30 |
$-3.10 |
| 2017-03-31 |
$-2.70 |
| 2016-12-31 |
$-3.10 |
| 2016-09-30 |
$-3.40 |
| 2016-06-30 |
$-3.50 |
| 2016-03-31 |
$-2.90 |
| 2015-12-31 |
$-2.90 |
| 2015-09-30 |
$-2.50 |
| 2015-06-30 |
$-2.70 |
| 2015-03-31 |
$-2.00 |
| 2014-12-31 |
$-2.00 |
| 2014-09-30 |
$-2.00 |
| 2014-06-30 |
$-1.90 |
| 2014-03-31 |
$-1.20 |
| 2013-12-31 |
$-1.20 |
| 2013-09-30 |
$-1.00 |
| 2013-06-30 |
$-1.00 |
| 2013-03-31 |
$-0.90 |
| 2012-12-31 |
$0.00 |
| 2012-10-31 |
$-0.70 |
| 2012-09-30 |
$-1.50 |
| 2012-07-31 |
$0.00 |
| 2012-06-30 |
$-0.95 |
| 2012-04-30 |
$-0.30 |
| 2012-03-31 |
$-0.30 |
| 2012-01-31 |
$-0.30 |
| 2011-10-31 |
$-0.40 |
| 2011-07-31 |
$0.00 |
| 2011-04-30 |
$-0.10 |
| 2011-01-31 |
$0.00 |
| 2010-10-31 |
$0.10 |
| 2010-07-31 |
$0.00 |
| 2010-04-30 |
$-0.30 |
| 2010-01-31 |
$-0.40 |
| 2009-10-31 |
$-0.40 |
| 2009-07-31 |
$0.00 |
| 2009-04-30 |
$-0.20 |
| 2009-01-31 |
$-0.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.001B |
$0.012B |
|
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
|
